Bromhexine Hydrochloride - CAS 611-75-6
Catalog number:
611-75-6
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C14H20Br2N2.HCl
Molecular Weight:
412.59
COA:
Inquire
Targets:
Others
Description:
Bromhexine is a mucolytic (expectorant) agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. In addition, bromhexine has antioxidant properties.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
MSDS:
Inquire
1.Mucosolvan serves to optimize perioperative airway management for NSCLC patients in fast track surgery: a randomized placebo controlled study.
Wang JY1, Hong X, Chen GH, Li QC, Liu ZM. Eur Rev Med Pharmacol Sci. 2015 Aug;19(15):2875-81.
OBJECTIVE: This study is conducted to investigate whether mucosolvan may offer therapy optimization initiatives for airway perioperative management of patients with non-small cell lung cancer (NSCLC) in fast track surgery (FTS).
2.Ambroxol inhalation ameliorates LPS-induced airway inflammation and mucus secretion through the extracellular signal-regulated kinase 1/2 signaling pathway.
Zhang SJ1, Jiang JX2, Ren QQ1, Jia YL2, Shen J2, Shen HJ2, Lin XX2, Lu H3, Xie QM4. Eur J Pharmacol. 2016 Mar 15;775:138-48. doi: 10.1016/j.ejphar.2016.02.030. Epub 2016 Feb 10.
Ambroxol, a metabolite of bromhexine, is shown to exert several pharmacological activities, including secretolytic, anti-inflammatory and antioxidant actions. Oral and intravenous administration of ambroxol is useful for the airway inflammatory diseases. However, little is known about its potential in inhalation therapy for lipopolysaccharide (LPS)-induced mucous hypersecretion and inflammatory response. In the present study, we compared the pharmacological effects of ambroxol by inhalation with intravenous administration and preliminarily explored its mechanism of action. Our results demonstrated that ambroxol administered by inhalation inhibited MUC5AC expression, reduced glycosaminoglycan levels, enhanced the function of mucociliary clearance and promoted sputum excretion, suggesting that ambroxol increases expectoration of sputum by reducing its viscosity. Moreover, ambroxol significantly alleviated LPS-induced the influx of inflammatory cells and the extracellular signal-regulated kinase 1/2 (Erk 1/2) expression in lung tissues, and inhibited increases in the mRNA expression of the pro-inflammatory cytokines tumor necrosis factor (TNF)-α, CCL-2 (monocyte chemotactic protein-1), KC (keratinocyte cell protein) and interleukin (IL)-1β in lung tissues.
3.Oxygen-driving and atomized mucosolvan inhalation combined with holistic nursing in the treatment of children severe bronchial pneumonia.
Yang F1. Pak J Pharm Sci. 2015 Jul;28(4 Suppl):1477-80.
This paper aimed to discuss the method, effect and safety of oxygen-driving and atomized Mucosolvan inhalation combined with holistic nursing in the treatment of children severe bronchial pneumonia. Totally 90 children with severe bronchial pneumonia who were treated in our hospital from March 2013 to November 2013 were selected as the research objects. Based on randomized controlled principle, those children were divided into control group, test group I and test group II according to the time to enter the hospital, 30 in each group. Patients in control group was given conventional therapy; test group I was given holistic nursing combined with conventional therapy; test group II was given oxygen-driving and atomized Mucosolvan inhalation combined with holistic nursing on the basis of conventional therapy. After test, the difference of main symptoms in control group, test group I and II was of no statistical significance (P>0.05). Test group II was found with the best curative effect, secondary was test group I and control group was the last.
4.Synergy of ambroxol with vancomycin in elimination of catheter-related Staphylococcus epidermidis biofilm in vitro and in vivo.
Zhang Y1, Fu Y1, Yu J2, Ai Q1, Li J1, Peng N1, Song S1, He Y1, Wang Z1. J Infect Chemother. 2015 Nov;21(11):808-15. doi: 10.1016/j.jiac.2015.08.017. Epub 2015 Sep 28.
Central venous catheters are widely used in neonatal intensive care units (NICUs) nowadays. The commonest cause of catheter-related bloodstream infections (CRBSIs) is coagulase-negative staphylococci (CoNS). Ambroxol, an active metabolite of bromhexine, exhibits antimicrobial activity against strains producing biofilm and enhances the bactericidal effect of some antibiotic by breaking the structure of biofilm. In this study, we aimed to determine the effect of ambroxol with vancomycin on the biofilm of Staphylococcus epidermidis (S. epidermidis) in vitro and in vivo. In the in vitro study, the biofilm of S. epidermidis was assessed by XTT reduction assay and analysed by confocal laser scanning microscopy (CLSM). In the in vivo study, a rabbit model of CRBSIs was created by intravenous intubation with a tube covered with S. epidermidis biofilm. The rabbits received one of the following four treatments by means of antibiotic lock therapy: normal heparin, ambroxol, vancomycin, or vancomycin plus ambroxol each for 3 days.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 329216-63-9 Quetiapine metabolite Quetiapine sulfoxide

Quetiapine metabolite Quetiapine sulfoxi
(CAS: 329216-63-9)

Quetiapine metabolite Quetiapine sulfoxide, a metabolite of Quetiapine, has antipsychotic effect.

ITX-5061
(CAS: 848144-15-0)

ITX-5061 is a scavenger receptor B1 antagonist. Preclinical studies show that ITX-5061 is a selective inhibitor of HCV entry into hepatocytes. It can prevent vi...

CAS 148554-65-8 seco Rapamycin Sodium Salt

seco Rapamycin Sodium Salt
(CAS: 148554-65-8)

Seco-rapamycin is the first in vivo open-ring metabolite of rapamycin which is a natural macrolide immunosuppressant. Seco-rapamycin inhibits the ChT-L (D) and ...

LY-186126
(CAS: 100644-00-6)

LY 186126 is a potent cGI-PDE inhibitor. It exhibit reversible and high affinity binding to a single class of SaR binding sites.

CAS 632-85-9 Wogonin

Wogonin
(CAS: 632-85-9)

Wogonin is a cell-permeable and orally available flavonoid that displays anti-inflammatory and anticancer properties.

Monohydroxy Netupitant
(CAS: 910808-12-7)

Monohydroxy Netupitant is the metabolite of Netupitant which is a potent and selective neurokinin-1 receptor (NK1) receptor antagonist. It is achiral and orally...

CAS 178925-65-0 APC-366

APC-366
(CAS: 178925-65-0)

APC-366, an amino acid derivative, has been found to be a mast cell tryptase inhibitor and was once studied against asthma by Celera Genomics Group. Ki: 7.1 μM.

CAS 80418-24-2 Notoginsenoside R1

Notoginsenoside R1
(CAS: 80418-24-2)

Notoginsenoside R1 is extracted from the roots of Panax notoginseng (Burk.)F.H.Chen. It has some neuronal protective, antihypertensive effects and exhibits anti...

CAS 18642-23-4 Psoralidin

Psoralidin
(CAS: 18642-23-4)

Psoralidin is a furanocoumarin natural product used in Chinese medicine. Psoralidin, a PTP1B inhibitor, has been shown to have anticancer activity with a variet...

CAS 199666-03-0 Ro 61-8048

Ro 61-8048
(CAS: 199666-03-0)

Potent and competitive kynurenine 3-hydroxylase inhibitor (IC50 = 37 nM). Shows antidystonic, anticonvulsant and neuroprotective effects in vivo. Blood-brain ba...

BMS-195270
(CAS: 202822-23-9)

CAS 1037184-44-3 YK-4-279

YK-4-279
(CAS: 1037184-44-3)

YK-4-279 is a potent inhibitor of EWS-FLI1 binding to RNA helicase A (RHA).YK-4-279 eliminates cyclin D levels by blocking the interaction of EWS-FLI1 with RHA ...

CAS 105462-24-6 Risedronate

Risedronate
(CAS: 105462-24-6)

Risedronate is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget's disease of bone.

AM-2159
(CAS: 83654-06-2)

AM-2159 is a bio-active chemical, but no detailed information has been published yet.

CAS 58-46-8 Tetrabenazine

Tetrabenazine
(CAS: 58-46-8)

Tetrabenazine is a VMAT-inhibitor used for treatment of hyperkinetic movement disorder. It is a monoamine-depleting and a dopamine-receptor-blocking drug and is...

CAS 5041-82-7 Isorhamnetin-3-O-beta-D-Glucosid

Isorhamnetin-3-O-beta-D-Glucosid
(CAS: 5041-82-7)

Isorhamnetin-3-O-beta-D-Glucoside from S. herbacea is a leading compound for further study as a new drug for the prevention and/or treatment of diabetes and its...

CAS 64302-87-0 R162

R162
(CAS: 64302-87-0)

R162 is a potent, selectiv inhibitor of glutamate dehydrogenase 1 (GDH1) (Ki = 28.6 µM), with anti-cancer properties. It does not inhibit the activity of other ...

CAS 7235-40-7 β Carotene

β Carotene
(CAS: 7235-40-7)

Beta Carotene is an organic compound and classified as a terpenoid. It is a precursor (inactive form) of vitamin A.

FY26 (complex)
(CAS: 1255143-82-8)

This active moleculr is a Os(II) anticancer drug candidate. It can generate reactive oxygen species and disrupt the redox balance in cancer cells. Using FY26 an...

CAS 99-15-0 Ac-DL-Leu-OH

Ac-DL-Leu-OH
(CAS: 99-15-0)

Acetylleucine is a drug mianly used to treat the vertigo.It has been listed.

Chemical Structure

CAS 611-75-6 Bromhexine Hydrochloride

Quick Inquiry

Verification code

Featured Items